Patent Dispute over CRISPR Gene-Editing Technology May Determine Who Will Be Paid Licensing Royalties by Medical Laboratories

U.S. Patent and Trademark Office will hold hearings to determine whether University of California Berkeley, or Broad Institute of Harvard and MIT, should receive patents for new genomic engineering technique In the race to master gene-editing in ways that will advance genetic medicine and patient care, one of the hottest technologies is CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats. But now a patent fight has the potential to complicate how pathologists and...

Human Longevity Inc. Unleashes Power of Whole-Genome Sequencing to Unlock Keys to Healthy Aging; Research May Lead to New Clinical Laboratory Tests

Human genome pioneer J. Craig Venter’s newest project seeks to ‘change the way medicine is practiced’ by creating genomic-based medicine model With little fanfare or public notice, a start-up company in San Diego is busy sequencing the largest number of whole human genome sequences in the world. The knowledge expected to result from this effort promises to revolutionize healthcare, as well as clinical laboratory testing. Human Longevity Inc. (HLI) is a genomics and cell therapy company that...

China’s Genome-Mapping Giant BGI Is Poised to Become an International Leader in Gene Sequencing and May Play Major Role in Interpretation of Genetic Test Results

However, China has a shortage of well-trained pathologists, which is why some American lab organizations are establishing medical lab testing ventures in China If experts are right, a company in China is poised to become the world’s largest at gene sequencing. In addition, the huge volume of genetic data it generates is expected to give this company the world’s largest database of genetic information. Such developments could mean that, in just a few years, many pathologists and molecular...

New York’s Mount Sinai Medical Center Using Big Data to Improve Clinical Care

Big data is poised to change the healthcare ecosystem and that creates opportunities for forward-looking medical laboratories First-mover academic center, Mount Sinai Medical Center (MSMC), is taking steps to incorporate “big data” into the daily patient-care setting. For the medical laboratory industry, this is a signal event because a major component of healthcare big data will be patient genetic and molecular information. Included on MSMC’s big data team are  its genetics laboratory...

Pathology Laboratory in an Ingestible Pill? Not Yet, But Maybe Sooner than You Think

Proteus Biomedical, Inc. prepares to launch a “smart pill” to remotely monitor how medication affects patients. If some experts are correct, it won’t take long to create ingestible devices that are capable of conducting clinical laboratory tests within the body. These devices would transmit the laboratory test results to physicians over the Internet by using wireless technology. As soon as 2011, Proteus Medical, Inc., of Redwood City, California, says it expects to introduce an ingestible...